Under the deal, which was announced in January, Walgreens will receive $6.275 billion in cash and 2 million shares of AmerisourceBergen common stock. The company said it used some of the money to eliminate $3.3 billion in debt from its balance sheet. The rest of the sale’s proceeds will go toward company growth and healthcare investments.
The companies said the transaction will allow AmerisourceBergen to provide more global support to pharmacies and drugmakers.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
